Biotechnology Investment Today Company Profile

04:24 EDT 19th June 2018 | BioPortfolio

Biotechnology Investment Today Biotechnology Investment Today (B.I.T.) provides industry stakeholders, both scientists and financers, with original and relevant data, information and knowledge on all aspects of the biotechnology industry. To this end, the company has developed a highly respected product portfolio, comprising its magazine, which reaches over 80,000 readers annually, its series of BioBusiness seminars and its website.

The B.I.T. magazine reaches a global audience of senior decision-makers and provides them with thought-provoking, timely and qualitative insights to critical industry issues. The content originates from industry leaders, government policy makers, market makers and analysts. It is our mission to serve the growing need for constantly updated information by Biotech CEOs and those in equivalent positions, institutional investors and venture capitalists eager to identify new and exciting business opportunities.

The renowned and highly acclaimed BioBusiness Seminar Series ensure that B.I.T. continue to maintain and further develop close relationships with the principal stakeholders in the industry. The seminars enable investors to immerse themselves in an environment which encourages, and is conducive to senior management meetings. The relaxed format allows questions to be openly asked and the conclusions drawn on company potential facilitate real business development.

Our website enables users to locate information regarding new scientific and financial developments quickly and easily providing them with an invaluable aid in identifying new investment opportunities. Our mission is to help companies by


60 Wharf Road
N1 7SF
United Kingdom


Phone: 44 (0)20 7253 5440
Fax: 44 (0)20 7253 9543

News Articles [1443 Associated News Articles listed on BioPortfolio]

Merck and three partners start ExploreBio, a € 20 million pre-seed investment initiative in Israel

Merck, a leading science and technology company, today announced ExploreBio, a pre-seed-investment vehicle by four investment funds targeted at early-stage companies in the biotechnology landscape in ...

ADC Bio secures investment

ADC Biotechnology, announces that it has secured £1.14 million in funding from investment managers, Downing LLP. The funds will bolster the company’s business drive for faster penetration of the ma...

Merck partners on 20 million-euro pre-seed investment initiative in Israel

Merck KGaA today announced the creation of ExploreBio, a pre-seed-investment vehicle by four investment…

Clal Biotechnology Industries (CBI) - Portfolio progress continues

Edison Investment Research - Pharmaceutical & healthcare - Clal Biotechnology Industries: Clal Biotechnology Industries’ (CBI) portfolio of investments continues to demonstrate forward-looking b...

CSBR Up 36% This Month, ZIOP Hit By Clinical Hold, Watch Out For SRPT Today

Today's Daily Dose brings you news about Royalty Pharma's investment in Biohaven Pharma; Champions Oncology's partnership with NSABP Foundation and Puma Biotechnology; upcoming regulatory catalyst of ...

Industry report calls for greater investment in pain and addiction therapies

A new report from US-based Biotechnology Innovation Organization (BIO) advocates greater levels of investment…

Pfizer unveils $600m investment in venture capital arm

Pfizer is planning to invest $600 million in biotechnology and other emerging growth companies through its venture investment group.

Clal Biotechnology Industries (CBI) - Israeli science, worldwide presence

Edison Investment Research - Pharmaceutical & healthcare - Clal Biotechnology Industries: We are initiating coverage on Clal Biotechnology Industries (CBI), an Israel/Boston-based healthcare investmen...

Drugs and Medications [43 Associated Drugs and Medications listed on BioPortfolio]

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint

Act restoring anticavity fluoride cool splash mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Mint 2x

Act restoring anticavity fluoride cool splash spearmint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint

Act restoring anticavity fluoride mouthwash cool splash spearmint 2x [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Spearmint 2X

Act restoring anticavity fluoride cool splash vanilla mint [Chattem, Inc.]

ACT Restoring Anticavity Fluoride Mouthwash Cool Splash Vanilla Mint

PubMed Articles [662 Associated PubMed Articles listed on BioPortfolio]

A network for early childhood development.

Political action and investment are critical to meet the development needs of vulnerable young children today. Early childhood development (ECD) has become a global priority: an ECD target and other E...

Opportunities in biotechnology.

Strategies for biotechnology must take account of opportunities for research, innovation and business growth. At a regional level, public-private collaborations provide potential for such growth and t...

Return on Investment Analysis of Breast Cancer Screening and Downstaging in Egypt: Implications for Developing Countries.

The aim of this study was to perform a return-on-investment (ROI) analysis of a breast cancer screening program in Egypt by comparing net profit in treatment costs saved to program cost investment.

Next generation industrial biotechnology based on extremophilic bacteria.

Industrial biotechnology aims to produce bulk chemicals including polymeric materials and biofuels based on bioprocessing sustainable agriculture products such as starch, fatty acids and/or cellulose....

'Bioexit': navigating the policy and regulatory pathways for the biotechnology industry in a post-Brexit landscape.

The withdrawal of the UK from the European Union (EU) is a complicated event. Although implications vary by industry, the biotechnology sector is especially vulnerable to the consequences of Brexit. A...

Clinical Trials [371 Associated Clinical Trials listed on BioPortfolio]

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Determine Return on Investment in Heart Failure Remote Monitoring Program

The study will test a hypothesis that the remote monitoring with text and email alerts sent to study subject and optional family/other caregiver (Intervention 1) will have a higher return ...

TODAY! A Mobile App Study

The aim of this study is to conduct a small randomized controlled trial (RCT) for a 10-week mobile phone intervention using principles of Cognitive Behavior Therapy to target general and m...

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY)

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has sponsored a consortium of investigators to conduct a clinical tr...

Mother-Child Relationships During Pregnancy Among Bofi Foragers

This study will examine changes in mother-child relationships when mothers are pregnant, because this period may involve conflicts between mothers and children. A widely held evolutionary...

Companies [2514 Associated Companies listed on BioPortfolio]

Biotechnology Investment Today

Biotechnology Investment Today Biotechnology Investment Today (B.I.T.) provides industry stakeholders, both scientists and financers, with original and relevant data, information and knowledge on all ...

European partnering & Invest Conference

EPIC is a biotechnology conference which showcases over 60 UK and European biotechnology companies. It is the perfect opportunity to hear from and meet a range of growing biotechnology companies who n...


Mulligan Biocapital AG is an investment firm dedicated to the life sciences with a specific focus on biotechlology with healt care applications.We invest in North Amercn and european biotechnology ven...

venBio Select Advisor LLC

venBio Select Advisor LLC (“venBio Select”) is the SEC registered investment manager for venBio’s public markets strategy and its main equity investment vehicle â...

China Development Financial Holding Corporation

CDIB pioneered venture capital and investment banking in Taiwan and today it remains the predominant leader in venture capital business in Taiwan with a market share of over 30%. Along with Taiwan’s...

More Information about "Biotechnology Investment Today" on BioPortfolio

We have published hundreds of Biotechnology Investment Today news stories on BioPortfolio along with dozens of Biotechnology Investment Today Clinical Trials and PubMed Articles about Biotechnology Investment Today for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biotechnology Investment Today Companies in our database. You can also find out about relevant Biotechnology Investment Today Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Corporate Database Quicklinks

Searches Linking to this Company Record